Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|November 8, 2006
Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1Christina Westmose Yde, Olaf-Georg Issinger
Molecular Cancer Therapeutics|June 19, 2007
Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell deathChristina Westmose Yde, Mads Gyrd-Hansen, Anne E Lykkesfeldt, et al.
Cancer Letters|July 17, 2007
Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMATChristina Westmose Yde, Thomas Frogne, Anne E Lykkesfeldt, et al.
Head and Neck Pathology|February 18, 2017
Genetic Characterization of Adenoid Cystic Carcinoma of the Minor Salivary Glands: A Potential Familial Occurrence in First-Degree RelativesHani Ibrahim Channir, Thomas van Overeem Hansen, Simon Andreasen, et al.
BMC Cancer|December 16, 2022
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON studyMartina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, et al.
Cancer Genetics|November 5, 2016
A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytomaChristina Westmose Yde, Astrid Sehested, Àngels Mateu-Regué, et al.
Cancer Genetics|April 29, 2017
Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningiomaMaria Rossing, Christina Westmose Yde, Astrid Sehested, et al.
British Journal of Cancer|June 13, 2019
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patientsIda Viller Tuxen, Lise Barlebo Ahlborn, Morten Mau-Soerensen, et al.
Neuro-Oncology|May 2, 2024
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patientsJosephine D Hendriksen, Alessio Locallo, Simone Maarup, et al.
Molecular Oncology|May 21, 2021
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective studyDorte Schou Nørøxe, Aidan Flynn, Christina Westmose Yde, et al.
Pageof 3